<VariationArchive VariationID="1299583" VariationName="NM_005859.5(PURA):c.531del (p.Pro178fs)" VariationType="Deletion" Accession="VCV001299583" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-05-01" DateCreated="2021-10-16" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1289637" VariationID="1299583">
      <GeneList>
        <Gene Symbol="PURA" FullName="purine rich element binding protein A" GeneID="5813" HGNC_ID="HGNC:9701" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="140114109" stop="140125619" display_start="140114109" display_stop="140125619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="139493707" stop="139499000" display_start="139493707" display_stop="139499000" Strand="+" />
          </Location>
          <OMIM>600473</OMIM>
          <Haploinsufficiency last_evaluated="2017-06-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PURA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-06-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PURA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005859.5(PURA):c.531del (p.Pro178fs)</Name>
      <CanonicalSPDI>NC_000005.10:140114707:GGGGG:GGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="140114708" stop="140114708" display_start="140114708" display_stop="140114708" variantLength="1" positionVCF="140114707" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="139494293" stop="139494293" display_start="139494293" display_stop="139494293" variantLength="1" positionVCF="139494292" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P178fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.140114712del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.140114712del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.139494297del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.139494297del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_041813.1" sequenceAccession="NG_041813" sequenceVersion="1" change="g.5590del">
            <Expression>NG_041813.1:g.5590del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005859.5" sequenceAccession="NM_005859" sequenceVersion="5" change="c.531del" MANESelect="true">
            <Expression>NM_005859.5:c.531del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005850.1" sequenceAccession="NP_005850" sequenceVersion="1" change="p.Pro178fs">
            <Expression>NP_005850.1:p.Pro178fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005859.5" sequenceAccession="NM_005859" sequenceVersion="5" change="c.527delG" MANESelect="true">
            <Expression>NM_005859.5:c.527delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2126749210" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005859.5(PURA):c.531del (p.Pro178fs) AND PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome" Accession="RCV001730056" Version="1">
        <ClassifiedConditionList TraitSetID="20405">
          <ClassifiedCondition DB="MedGen" ID="C4015357">PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005859.5(PURA):c.531del (p.Pro178fs) AND PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation" Accession="RCV002471138" Version="1">
        <ClassifiedConditionList TraitSetID="41026">
          <ClassifiedCondition DB="MedGen" ID="CN924912">PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005859.5(PURA):c.531del (p.Pro178fs) AND Inborn genetic diseases" Accession="RCV002343805" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-06-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-02" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-10-16" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">29097605</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">28448108</ID>
          <ID Source="BookShelf">NBK426063</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="20405" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32585" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEURODEVELOPMENTAL DISORDER WITH NEONATAL RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND FEEDING DIFFICULTIES</ElementValue>
                <XRef Type="MIM" ID="616158" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome</ElementValue>
                <XRef ID="MONDO:0018580" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEDRIHF</ElementValue>
                <XRef Type="MIM" ID="616158" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">PURA-Related Neurodevelopmental Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PURA-related neurodevelopmental disorders include PURA syndrome, caused by a heterozygous pathogenic sequence variant in PURA, and 5q31.3 deletion syndrome, caused by a genomic 5q31.3 deletion encompassing all or part of PURA.
PURA-related neurodevelopmental disorders are characterized by moderate-to-severe neurodevelopmental delay with absence of speech in most and lack of independent ambulation in many. Early-onset problems can include hypotonia, hypothermia, hypersomnolence, feeding difficulties, excessive hiccups, recurrent central and obstructive apneas, epileptic seizures, abnormal nonepileptic movements (dystonia, dyskinesia, and dysconjugate eye movements), and abnormal vision. Congenital heart defects, urogenital malformations, skeletal abnormalities, and endocrine disorders occur, but are less common.</Attribute>
                <XRef ID="NBK426063" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PURA-Related Neurologic Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28448108</ID>
                <ID Source="BookShelf">NBK426063</ID>
              </Citation>
              <XRef ID="438213" DB="Orphanet" />
              <XRef ID="438216" DB="Orphanet" />
              <XRef ID="C4015357" DB="MedGen" />
              <XRef Type="MIM" ID="616158" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="41026" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38804" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation</ElementValue>
                <XRef ID="MONDO:0014512" DB="MONDO" />
                <XRef ID="438216" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17740" />
                <XRef ID="17740" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="438216" DB="Orphanet" />
              <XRef ID="CN924912" DB="MedGen" />
              <XRef ID="MONDO:0014512" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3867651" SubmissionDate="2021-10-09" DateLastUpdated="2021-10-16" DateCreated="2021-10-16">
        <ClinVarSubmissionID localKey="NM_005859.5:c.527delG|OMIM:616158" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001976841" DateUpdated="2021-10-16" DateCreated="2021-10-16" Type="SCV" Version="1" SubmitterName="Laboratory of Medical Genetics, National &amp; Kapodistrian University of Athens" OrgID="506664" OrganizationCategory="laboratory" OrgAbbreviation="LMG-NKUA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PM2, PM6</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PURA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005859.5:c.527delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616158" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10504991</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5414662" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_005859_4_PURA_c_531delG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002766888" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28448108</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29097605</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is likely a mechanism of disease in this gene and is associated with neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties (MIM#616158; PMID: 28448108). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity (PMID: 29097605). (I) 0204 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with at least 1/3 of the protein sequence affected. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other downstream truncating variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. This variant has been classified as pathogenic by a clinical laboratory in ClinVar. (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed) (by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PURA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_15678</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005859.4:c.531delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0014512" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5131682" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a490321|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002646798" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.531delG pathogenic mutation, located in coding exon 1 of the PURA gene, results from a deletion of one nucleotide at nucleotide position 531, causing a translational frameshift with a predicted alternate stop codon (p.P178Lfs*47). This alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PURA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005859.4:c.531delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3867651" TraitType="Disease" MappingType="XRef" MappingValue="616158" MappingRef="OMIM">
        <MedGen CUI="C4015357" Name="PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5131682" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5414662" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0014512" MappingRef="MONDO">
        <MedGen CUI="CN924912" Name="PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

